Fizazi, Karim <br/><br/>
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 2009 
 - 1564-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2008.19.2146  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--pharmacokinetics<br/>Antibodies, Monoclonal, Humanized<br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Neoplasms--complications<br/>Bone Resorption--chemically induced<br/>Breast Neoplasms--pathology<br/>Collagen Type I--urine<br/>Denosumab<br/>Diphosphonates--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--pathology<br/>Peptides--urine<br/>Prostatic Neoplasms--pathology<br/>RANK Ligand--antagonists & inhibitors